Barth J and Hahne W |
Review article: rabeprazole-based therapy in Helicobacter pylori eradication. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11849125
|
Tomioka H et al. |
Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex. |
2002 |
Int. J. Antimicrob. Agents |
pmid:11850167
|
Sharara AI et al. |
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in Lebanon. |
2002 |
Int. J. Antimicrob. Agents |
pmid:11850169
|
Krause M |
[Resistance problems in gastrointestinal infections]. |
2002 |
Ther Umsch |
pmid:11851045
|
Al-Eidan FA et al. |
Management of Helicobacter pylori eradication--the influence of structured counselling and follow-up. |
2002 |
Br J Clin Pharmacol |
pmid:11851640
|
Sheu BS et al. |
Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11856088
|
Choi IJ et al. |
Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11856089
|
Bazzoli F et al. |
Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11856090
|
Rhomberg PR and Jones RN |
In vitro activity of 11 antimicrobial agents, including gatifloxacin and GAR936, tested against clinical isolates of Mycobacterium marinum. |
2002 |
Diagn. Microbiol. Infect. Dis. |
pmid:11858912
|
Malfertheiner P et al. |
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11860399
|
Kim JS et al. |
Effect of Helicobacter pylori eradication on duodenal ulcer scar in patients with no clinical history of duodenal ulcer. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11860410
|
Poon SK et al. |
Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11860412
|
Peitz U et al. |
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11860415
|
Masiá M et al. |
Fulminant hepatitis and fatal toxic epidermal necrolysis (Lyell disease) coincident with clarithromycin administration in an alcoholic patient receiving disulfiram therapy. |
2002 |
Arch. Intern. Med. |
pmid:11863483
|
Lim JA et al. |
Prevalence of resistance to macrolide, lincosamide and streptogramin antibiotics in Gram-positive cocci isolated in a Korean hospital. |
2002 |
J. Antimicrob. Chemother. |
pmid:11864949
|
Fujimura S et al. |
In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults. |
2002 |
J. Antimicrob. Chemother. |
pmid:11864956
|
Levy M et al. |
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. |
2002 |
Am. J. Gastroenterol. |
pmid:11866264
|
Christopher K et al. |
Clarithromycin use preceding fulminant hepatic failure. |
2002 |
Am. J. Gastroenterol. |
pmid:11866297
|
Narayani RI et al. |
Resolution of collagenous colitis after treatment for Helicobacter pylori. |
2002 |
Am. J. Gastroenterol. |
pmid:11866305
|
Malik R et al. |
Feline leprosy: two different clinical syndromes. |
2002 |
J. Feline Med. Surg. |
pmid:11869054
|
Shcherbakov PL |
[Clarithromycin in eradication therapy of helicobacter infections in children]. |
2001 |
Antibiot. Khimioter. |
pmid:11871315
|
Kumar D et al. |
Pre and post eradication gastric inflammation in Helicobacter pylori-associated duodenal ulcer. |
2002 Jan-Feb |
Indian J Gastroenterol |
pmid:11871846
|
Colebunders R and Florence E |
Neuropsychiatric reaction induced by clarithromycin. |
2002 |
Sex Transm Infect |
pmid:11872875
|
Khan J and Javed M |
The incidence of non ulcer dyspepsia and its response to treatment. |
2001 Oct-Dec |
J Ayub Med Coll Abbottabad |
pmid:11873428
|
Dabernat H et al. |
[in vitro activity of telithromycin against Haemophilus influenzae]. |
2002 |
Pathol. Biol. |
pmid:11873632
|
Di Caro S et al. |
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11876707
|
Wu JC et al. |
Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11876709
|
Mason J et al. |
The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11876711
|
Georgopoulos SD et al. |
Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11876712
|
Elizalde JI et al. |
Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11876713
|
Okada S et al. |
Angiocentric immunoproliferative lesions of the lung associated with diffuse renal involvement. |
2002 |
Am. J. Kidney Dis. |
pmid:11877592
|
Melo-Cristino J et al. |
[Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000]. |
|
Acta Med Port |
pmid:11878155
|
Biechy M et al. |
[Soft-tissue abscess caused by Rhodococcus equi in a patient on hemodialysis]. |
2001 |
Nefrologia |
pmid:11881436
|
Ecclissato C et al. |
Increased primary resistance to recommended antibiotics negatively affects Helicobacter pylori eradication. |
2002 |
Helicobacter |
pmid:11886474
|
van Rooyen GF et al. |
Sensitive liquid chromatography-tandem mass spectrometry method for the determination of clarithromycin in human plasma. |
2002 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:11890168
|
Murata Y et al. |
[Study on the detection methods of Helicobacter pylori from clinical specimens]. |
2002 |
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi |
pmid:11895427
|
Klein JL et al. |
Prosthetic valve endocarditis caused by Bartonella quintana. |
2002 |
Emerging Infect. Dis. |
pmid:11897074
|
Galarza M et al. |
Pediatric granulomatous cerebral amebiasis: a delayed diagnosis. |
2002 |
Pediatr. Neurol. |
pmid:11897483
|
Ménard A et al. |
PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11897613
|
Grove DI and Koutsouridis G |
Increasing resistance of Helicobacter pylori to clarithromycin: is the horse bolting? |
2002 |
Pathology |
pmid:11902451
|
Kornacker M et al. |
Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases. |
2002 |
Ann. Hematol. |
pmid:11907791
|
McNulty C et al. |
Helicobacter pylori susceptibility testing by disc diffusion. |
2002 |
J. Antimicrob. Chemother. |
pmid:11909833
|
Thiermann S et al. |
Comparison of phenotypic and genotypic methods for the detection of clarithromycin resistance in Mycobacterium avium. |
2002 |
J. Antimicrob. Chemother. |
pmid:11909844
|
Kalach N et al. |
[Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children]. |
2002 |
Arch Pediatr |
pmid:11915493
|
Kawakami E et al. |
Triple therapy with clarithromycin, amoxicillin and omeprazole for Helicobacter pylori eradication in children and adolescents. |
2001 Jul-Sep |
Arq Gastroenterol |
pmid:11917721
|
Odaka T et al. |
Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy. |
2002 |
Am. J. Gastroenterol. |
pmid:11922552
|
Ozawa S |
[Drug-drug interaction in pharmacogenetics and pharmacogenomics]. |
2002 |
Rinsho Byori |
pmid:11925851
|
Morimoto T et al. |
[Cost-effectiveness analysis of ambulatory treatment for adult patients with community-acquired pneumonia: according to Japanese Respiratory Society guidelines]. |
2002 |
Nihon Kokyuki Gakkai Zasshi |
pmid:11925912
|
Takemura Y et al. |
[Mycobacterium abscessus infection complicated with diabetes mellitus]. |
2002 |
Nihon Kokyuki Gakkai Zasshi |
pmid:11925921
|
Ciancio G et al. |
Regression of duodenal gastric metaplasia in Helicobacter pylori positive patients with duodenal ulcer disease. |
2002 |
Dig Liver Dis |
pmid:11926569
|
Borody TJ et al. |
Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure? |
2002 |
Dig Liver Dis |
pmid:11926571
|
Bazzoli F et al. |
Treatment of Helicobacter pylori infection. Indications and regimens: an update. |
2002 |
Dig Liver Dis |
pmid:11926576
|
Hermon-Taylor J |
Treatment with drugs active against Mycobacterium avium subspecies paratuberculosis can heal Crohn's disease: more evidence for a neglected public health tragedy. |
2002 |
Dig Liver Dis |
pmid:11926580
|
Sinisalo J et al. |
Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome. |
2002 |
Circulation |
pmid:11927522
|
Pilotto A and Malfertheiner P |
Review article: an approach to Helicobacter pylori infection in the elderly. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11929385
|
Wong WM et al. |
One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11929398
|
Zheng X et al. |
[The prevalence and mechanism of Helicobacter pylori resistance to clarithromycin in Beijing]. |
2001 |
Zhonghua Yi Xue Za Zhi |
pmid:11930609
|
Shafran I et al. |
Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease. |
2002 |
Dig Liver Dis |
pmid:11930899
|
Treadway G et al. |
The safety of azithromycin in the treatment of adults with community-acquired respiratory tract infections. |
2002 |
Int. J. Antimicrob. Agents |
pmid:11932140
|
Böcher W et al. |
[Skin nodules and ulcers of the limbs in a patient with rheumatoid arthritis]. |
2002 |
Dtsch. Med. Wochenschr. |
pmid:11935470
|
Amsden GW et al. |
A study of the interaction potential of azithromycin and clarithromycin with atorvastatin in healthy volunteers. |
2002 |
J Clin Pharmacol |
pmid:11936570
|
Ohlin B et al. |
Dual versus triple therapy in eradication of Helicobacter pylori. |
2002 Jan-Feb |
Hepatogastroenterology |
pmid:11941946
|
Kountouras J et al. |
Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome. |
2002 Jan-Feb |
Hepatogastroenterology |
pmid:11941952
|
Hu YY et al. |
Antimicrobial susceptibility of Haemophilus influenzae among children in Beijing, China, 1999-2000. |
2002 |
Acta Paediatr. |
pmid:11951998
|
King A et al. |
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin. |
2002 |
Clin. Microbiol. Infect. |
pmid:11952721
|
Olalla J et al. |
Mycobacterium fortuitum complex endocarditis-case report and literature review. |
2002 |
Clin. Microbiol. Infect. |
pmid:11952729
|
Baena JM et al. |
Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week. |
2002 |
Eur J Gastroenterol Hepatol |
pmid:11953695
|
Tessier PR et al. |
Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11959578
|
Lin CK et al. |
One-week quadruple therapy is an effective salvage regimen for Helicobacter pylori infection in patients after failure of standard triple therapy. |
2002 May-Jun |
J. Clin. Gastroenterol. |
pmid:11960067
|
Klotz U |
Interaction potential of lercanidipine, a new vasoselective dihydropyridine calcium antagonist. |
2002 |
Arzneimittelforschung |
pmid:11963641
|
Uc A and Chong SK |
Treatment of Helicobacter pylori gastritis improves dyspeptic symptoms in children. |
2002 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:11964952
|
Klok RM et al. |
Continued utilization and costs of proton pump inhibitors after Helicobacter pylori eradication in chronic users of gastrointestinal drugs. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11966514
|
Tomita T et al. |
Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer disease. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11966543
|
Tsuzuki T et al. |
Clarithromycin increases the release of heat shock protein B from Helicobacter pylori. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11966545
|
Perri F et al. |
Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection. |
2002 |
Helicobacter |
pmid:11966868
|
Nagayama M et al. |
[Follicular bronchiolitis preceding rheumatoid arthritis]. |
2002 |
Nihon Kokyuki Gakkai Zasshi |
pmid:11974899
|
Takashima J et al. |
Derrisin, a new rotenoid from Derris malaccensis plain and anti-Helicobacter pylori activity of its related constituents. |
2002 |
J. Nat. Prod. |
pmid:11975515
|
Chiba N et al. |
Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial. |
2002 |
BMJ |
pmid:11976244
|
Giaconi J et al. |
Bilateral Mycobacterium abscessus keratitis after laser in situ keratomileusis. |
2002 |
J Cataract Refract Surg |
pmid:11978473
|
Paz A and Potasman I |
Mycoplasma-associated carditis. Case reports and review. |
2002 |
Cardiology |
pmid:11978954
|
Yamamoto N et al. |
[Development of Helicobacter pylori eradication therapy]. |
2002 |
Nippon Rinsho |
pmid:11979775
|
Imase K and Takahashi S |
[Diagnosis of Helicobacter pylori infection by culture method]. |
2002 |
Nippon Rinsho |
pmid:11979798
|
Murakami K and Nasu M |
[Drug sensitivity test for Helicobacter pylori]. |
2002 |
Nippon Rinsho |
pmid:11979806
|
Nakamura T |
[The outline of medical treatment of peptic ulcer]. |
2002 |
Nippon Rinsho |
pmid:11979808
|
Takeda H |
[Current role of acid suppressants in the treatment of peptic ulcer disease]. |
2002 |
Nippon Rinsho |
pmid:11979809
|
Kato M et al. |
[Guidelines for the management of Helicobacter pylori infection in Japan]. |
2002 |
Nippon Rinsho |
pmid:11979813
|
Kato S |
[Guidelines of Helicobacter pylori eradication in children]. |
2002 |
Nippon Rinsho |
pmid:11979815
|
Satoh K |
[New triple therapy for Helicobacter pylori infection]. |
2002 |
Nippon Rinsho |
pmid:11979817
|
Fu HY et al. |
[Dual therapy for Helicobacter pylori resistance to anti microbial agents]. |
2002 |
Nippon Rinsho |
pmid:11979819
|
Ohkusa T and Sato N |
[Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection]. |
2002 |
Nippon Rinsho |
pmid:11979821
|
Nagahara A et al. |
[Effect of PPI/AM re-treatment regimen for the patients with Helicobacter pylori infection after failure of first line eradication therapy by PPI/AC regimens]. |
2002 |
Nippon Rinsho |
pmid:11979822
|
Shirai N and Furuta T |
[High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy: CYP2C19 polymorphism]. |
2002 |
Nippon Rinsho |
pmid:11979823
|
Tokunaga K and Takahashi S |
[Second line treatment regimen of PPI + AMPC + MNZ for patients with clarithromycin-resistant Helicobacter pylori infection]. |
2002 |
Nippon Rinsho |
pmid:11979824
|
Sato R et al. |
[Minocycline-containing eradication therapy for patients with clarithromycin-resistant Helicobacter pylori infection]. |
2002 |
Nippon Rinsho |
pmid:11979825
|
Mitsuno Y and Yoshida H |
[Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication]. |
2002 |
Nippon Rinsho |
pmid:11979826
|
Kagaya H et al. |
[Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections]. |
2002 |
Nippon Rinsho |
pmid:11979827
|
Inoue K and Sugano K |
[Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection]. |
2002 |
Nippon Rinsho |
pmid:11979828
|
Miwa H et al. |
[Adverse effects of H. pylori eradication therapy and its measure]. |
2002 |
Nippon Rinsho |
pmid:11979829
|
Sakaki N |
[Acute mucosal lesion of the upper-gastrointestinal tract observed after H. pylori-eradication]. |
2002 |
Nippon Rinsho |
pmid:11979830
|
Haruma K et al. |
[H. pylori eradication therapy and natural history of peptic ulcer]. |
2002 |
Nippon Rinsho |
pmid:11979833
|